Our Response to COVID-19

Research & Support of SARS-CoV2 & COVID-19

We are guided by cutting-edge research, integrative medicine guidelines in China, and time tested practices.

 

There is a hospital in Henan, China that reported in early February on how they have implemented integrative medicine guidelines and prevention to protect all of their thousands of medical and hospital staff from being infected by coronavirus.  Not only are they using standard safety precautions and protective gear, they are also utilizing SARS protocols and giving them Chinese herbal formulas on an ongoing basis.  These guidelines were developed out of the 2003 SARS outbreak where three separate studies, looking at tens of thousands of subjects, showed successful prevention of contracting the disease by front-line healthcare workers taking herbal formulas (Luo et al., 2020).

 

For those who were not directly exposed or had lower risk, they were given a more gentle preventive herbal formula that they drank on a daily basis.


We are sourcing granules of the tea and have it available in our store.*

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

For those on the front lines providing direct care to infected COVID-19 patients or for those who were in higher risk categories, they were given more complex individualized herbal formulas on a daily basis.

 

And for COVID-19 patients, as soon as symptoms arose, they were treated with Chinese herbal formulas in conjunction with Western medicine.  “According to the current clinical guideline in China and the experiences in the treatment of SARS or Middle East Respiratory Syndrome (MERS) patients, both conventional medicine and traditional Chinese medicine (TCM) are used for the treatment of patients with infection of SARS-CoV 2 in China.” (Yang et al., 2020, p. 1708 -1709)

 

(Read the full report here.)

Our herbal pharmacy is here to support your health. Click here to see everything we have treated using the formulas in our pharmacy.  We are here for non-COVID-19 primary care as well.*

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

 

We will continue to provide herbal support to all of our existing patients and are currently accepting new patients looking for support. 



 

 

Sources:
 

Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet, 361(9374), 2045–2046. https://doi.org/10.1016/S0140-6736(03)13615-X

Fiore, C., Eisenhut, M., Krausse, R., Ragazzi, E., Pellati, D., Armanini, D., & Bielenberg, J. (2008). Antiviral effects of Glycyrrhiza species. Phytotherapy Research, 22(2), 141–148. https://doi.org/10.1002/ptr.2295

Luo, H., Tang, Q., Shang, Y., Liang, S., Yang, M., Robinson, N., & Liu, J. (2020). Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-020-3192-6

Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. International Journal of Biological Sciences, 16(10), 1708–1717. https://doi.org/10.7150/ijbs.45538

Additional Information and research will be added in the coming days.

Chan, K. W., Wong, V. T., & Tang, S. C. W. (2020). COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese–Western Medicine for the Management of 2019 Novel Coronavirus Disease. The American Journal of Chinese Medicine, 1–26. https://doi.org/10.1142/S0192415X20500378

Chen, Ji., Fan, H., Zhang, L., Huang, B., Zhu, M., Zhou, Y., Yu, W., Zhu, L., Cheng, S., Tao, X., & Zhang, H. (2020). Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19 [Preprint]. Intensive Care and Critical Care Medicine. https://doi.org/10.1101/2020.03.09.20033068

Chen, Y., Guo, J. J., Healy, D. P., & Zhan, S. (2007). Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis. Pharmacy Practice (Internet), 5(1). https://doi.org/10.4321/S1886-36552007000100001

Cui, H.-T., Li, Y.-T., Guo, L.-Y., Liu, X.-G., Wang, L.-S., Jia, J.-W., Liao, J.-B., Miao, J., Wang, L., Wang, H.-W., & Wen, W.-B. (n.d.). Traditional Chinese medicine for treatment of coronavirus disease 2019—A review. 9.

Fiore, C., Eisenhut, M., Krausse, R., Ragazzi, E., Pellati, D., Armanini, D., & Bielenberg, J. (2008). Antiviral effects of Glycyrrhiza species. Phytotherapy Research, 22(2), 141–148. https://doi.org/10.1002/ptr.2295

Huang, Z., Pan, X., Zhou, J., Leung, W. T., Li, C., & Wang, L. (n.d.). Chinese herbal medicine for acute upper respiratory tract infections and reproductive safety: A systematic review. Mechanism of Action, 13.

Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., Huang, Q., Han, Y., Hu, B., Hu, F., Li, B.-H., Li, Y.-R., Liang, K., Lin, L.-K., Luo, L.-S., … Wang, X.-H. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research, 7(1), 4. https://doi.org/10.1186/s40779-020-0233-6

Jo, S., Kim, S., Shin, D. H., & Kim, M.-S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 145–151. https://doi.org/10.1080/14756366.2019.1690480

Kim, Y., Narayanan, S., & Chang, K.-O. (2010). Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Research, 88(2), 227–235. https://doi.org/10.1016/j.antiviral.2010.08.016

Leung, P.-C. (2007). The Efficacy of Chinese Medicine for SARS: A Review of Chinese Publications After the Crisis. The American Journal of Chinese Medicine, 35(04), 575–581. https://doi.org/10.1142/S0192415X07005077

Li, X., Yu, J., Zhang, Z., Ren, J., Peluffo, A. E., Zhang, W., Zhao, Y., Yan, K., Cohen, D., & Wang, W. (2020). Network Bioinformatics Analysis Provides Insight into Drug Repurposing for COVID-2019 [Preprint]. MEDICINE & PHARMACOLOGY. https://doi.org/10.20944/preprints202003.0286.v1

Luo, H., Tang, Q., Shang, Y., Liang, S., Yang, M., Robinson, N., & Liu, J. (2020). Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-020-3192-6

Luo, Y., Wang, C.-Z., Hesse-Fong, J., Lin, J.-G., & Yuan, C.-S. (2019). Application of Chinese Medicine in Acute and Critical Medical Conditions. The American Journal of Chinese Medicine, 47(06), 1223–1235. https://doi.org/10.1142/S0192415X19500629

Sun, N., Wong, W.-L., & Guo, J. (2020). Prediction of potential 3CLpro-targeting anti-SARS-CoV-2 compounds from Chinese medicine. 13.

Wei, W., Du, H., Shao, C., Zhou, H., Lu, Y., Yu, L., Wan, H., & He, Y. (2019). Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A. Frontiers in Pharmacology, 10, 961. https://doi.org/10.3389/fphar.2019.00961

Wu, Q., Zhou, L., Sun, X., Yan, Z., Hu, C., Wu, J., Xu, L., Li, X., Liu, H., Yin, P., Li, K., Zhao, J., Li, Y., Wang, X., Li, Y., Zhang, Q., Xu, G., & Chen, H. (2017). Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Scientific Reports, 7(1), 9110. https://doi.org/10.1038/s41598-017-09536-z

Xiaoguang, W., & Zejing, L. (n.d.). Prevention and treatment of viral respiratory infections by traditional Chinese herbs. Chinese Medical Journal, 7.

Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. International Journal of Biological Sciences, 16(10), 1708–1717. https://doi.org/10.7150/ijbs.45538

Yuan, J., Kou, S., Liang, Y., Zeng, J., Pan, Y., & Liu, L. (2020). Clinical Characteristics on 25 Discharged Patients with COVID-19 Virus Returning [Preprint]. Infectious Diseases (except HIV/AIDS). https://doi.org/10.1101/2020.03.06.20031377

Zhang, D., Wu, K., Zhang, X., Deng, S., & Peng, B. (2020). In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 18(2), 152–158. https://doi.org/10.1016/j.joim.2020.02.005

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, S0140673620305663. https://doi.org/10.1016/S0140-6736(20)30566-3

  • White Yelp Icon
  • White Google+ Icon
  • White Facebook Icon
  • White Twitter Icon

Your contact information will not be sold or shared and you may opt out of emails at any time.

©2020 by Abundant Heaven Traditional Chinese Medicine.